Institut Català de la Salut
[Martínez Vallejo P, Mediavilla A, Rubio Maturana C] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Silgado A, Sulleiro E] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. [Zarzuela F] Unitat de Salut Internacional, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain. [Goterris L, Joseph Munne J] Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain. [Serre Delcor N] Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. Unitat de Salut Internacional, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain. [Oliveira Souto I, Salvador F, Aznar ML, Pou D, Treviño B, Molina I] Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. Unitat de Salut Internacional, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS Barcelona, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-08-21T08:23:59Z
2025-08-21T08:23:59Z
2025-05-30
Molecular diagnostics; Real-time PCR; Urogenital schistosomiasis
Diagnóstico molecular; PCR en tiempo real; Esquistosomiasis urogenital
Diagnòstic molecular; PCR en temps real; Esquistosomiasi urogenital
Background Schistosomiasis, a major neglected tropical disease, is caused by Schistosoma spp. It is estimated that more than 200 million people are affected worldwide, mostly in Africa. The gold standard diagnosis of urogenital schistosomiasis (UGS) is the microscopic visualisation of Schistosoma haematobium eggs in concentrated urine; however, its sensitivity is low. This study aimed to evaluate the effectiveness of molecular and serological testing for imported UGS screening in asymptomatic sub-Saharan migrants in a non-endemic setting. Methods A retrospective cross-sectional study between November 2021 and December 2022 was conducted by collecting demographic, clinical and laboratory data from the medical records of migrants from endemic areas screened for UGS at the International Health Unit Vall d’Hebron-Drassanes, Barcelona, Spain. Urine samples were analysed by real-time PCR for S. haematobium DNA and by microscopy for egg detection. Serum samples were tested using a serological assay based on enzyme-linked immunosorbent assay (ELISA). UGS was confirmed by a positive result in real-time PCR and/or microscopy, while possible UGS was defined as a case with only a positive serological result. Results A total of 604 patients were included in this study; 32 out of 604 (5.3%) urine samples were positive for S. haematobium by real-time PCR and/or microscopy examination (confirmed UGS cases). Schistosoma haematobium DNA was detected in 28/604 (4.6%) urine samples, while eggs were visualised in 24/604 (3.9%), with 12 discordant cases between both techniques. Real-time PCR demonstrated a sensitivity of 83.3%, a specificity of 98.6%, and a kappa value of 0.76. Serology was performed in 529/604 cases and exhibited lower specificity, 70.87% (kappa value 0.26). Other laboratory parameters such as leukocyturia, microhaematuria, eosinophilia and elevated IgE were significantly associated with UGS diagnosis. Conclusions Real-time PCR proved to be more sensitive than microscopy for diagnosing imported UGS in non-endemic settings, with minimal discordance between methods. The serological test exhibited very low specificity and high sensitivity rates, suggesting its usefulness as a screening test among high-risk populations in non-endemic settings.
Article
Published version
English
Cribatge (Medicina); Aparell urinari - Infeccions; Esquistosomiasi - Serodiagnòstic; Esquistosomiasi - Diagnòstic molecular; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Mass Screening; DISEASES::Bacterial Infections and Mycoses::Infection::Urinary Tract Infections::Schistosomiasis haematobia; Other subheadings::Other subheadings::/diagnosis; ORGANISMS::Eukaryota::Animals::Invertebrates::Helminths::Platyhelminths::Trematoda::Schistosomatidae::Schistosoma::Schistosoma haematobium; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Immunologic Tests::Serologic Tests; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Epidemiologic Research Design::Sensitivity and Specificity; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::cribado sistemático; ENFERMEDADES::infecciones bacterianas y micosis::infección::infecciones urinarias::esquistosomiasis urinaria; Otros calificadores::Otros calificadores::/diagnóstico; ORGANISMOS::Eukaryota::animales::invertebrados::helmintos::platelmintos::Trematoda::Schistosomatidae::Schistosoma::Schistosoma haematobium; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::técnicas de laboratorio clínico::pruebas inmunológicas::pruebas serológicas; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::diseño de la investigación epidemiológica::sensibilidad y especificidad
BMC
Parasites & Vectors;18
https://doi.org/10.1186/s13071-025-06832-w
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3440]